Share on StockTwits

West Pharmaceutical Services (NYSE:WST) Insider Heino Lennartz unloaded 7,555 shares of the stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $39.65, for a total value of $299,555.75. Following the transaction, the insider now directly owns 20,974 shares of the company’s stock, valued at approximately $831,619. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of West Pharmaceutical Services in a research note on Tuesday, August 5th. They now have a $45.00 price target on the stock, down previously from $47.00.

West Pharmaceutical Services (NYSE:WST) opened at 42.02 on Monday. West Pharmaceutical Services has a one year low of $36.77 and a one year high of $51.12. The stock’s 50-day moving average is $41. and its 200-day moving average is $43.44. The company has a market cap of $2.974 billion and a price-to-earnings ratio of 26.23.

West Pharmaceutical Services (NYSE:WST) last released its earnings data on Thursday, July 31st. The company reported $0.52 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.47 by $0.05. The company had revenue of $368.90 million for the quarter, compared to the consensus estimate of $368.60 million. During the same quarter last year, the company posted $0.86 earnings per share. West Pharmaceutical Services’s revenue was up 7.1% compared to the same quarter last year. On average, analysts predict that West Pharmaceutical Services will post $1.84 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Wednesday, November 5th. Stockholders of record on Wednesday, October 22nd will be paid a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a dividend yield of 1.05%.

West Pharmaceutical Services, Inc (NYSE:WST) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.